Current Continuous Process Validation Program

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for shortened drug approval review time.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 pharmaceutical firms, and various other life sciences stakeholders.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer immunotherapies.

The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics.